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mORONARY ARTERY DISEASE1257Serial IVUS Studies in Saphenous Vein Graftsoung Joon Hong, Gary S. Mintz, Sang Wook Kim, Sung Yun Lee, Seok Yeon Kim, Teruo Okabe,
ugusto D. Pichard, Lowell F. Satler, Ron Waksman, Kenneth M. Kent, William O. Suddath,
eil J. Weissman
hile several studies have used intravascular ultrasound (IVUS) to measure the patterns of
nd risk factors for plaque growth in native coronary arteries, there have been no serial IVUS
tudies in saphenous vein grafts (SVGs). Hong and colleagues performed serial IVUS studies
n SVGs. Minimum lumen area (MLA) decreased in two-thirds of lesions and increased in
he other one-third. There was a linear relationship between both plaque area and lumen
rea versus low-density lipoprotein (LDL) cholesterol; an LDL cholesterol 100 mg/dl
redicted no plaque increase. These findings demonstrate that lowering LDL may help to
everse plaque progression in SVGs, and are similar to findings in native coronary arteries.BESITY AND CV MORTALITY IN ESRD1265Waist Circumference Predicts Mortality Better Than BMI in ESRDCV
 d
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Body mass index
Cardiovascular death aurizio Postorino, Carmen Marino, Giovanni Tripepi, Carmine Zoccali, on behalf of the CREDIT
Calabria Registry of Dialysis and Transplantation) Working Group
urrogate measures of visceral fat, such as waist circumference and waist/hip ratio (WHR),
re stronger predictors of all-cause and cardiovascular (CV) death than body mass index
BMI) in the general population. Postorino and colleagues compared BMI and
nthropometric measurements in over 500 patients with end-stage renal disease (ESRD).
HR was an independent predictor of both all-cause and CV mortality; a 10-cm larger
aist circumference was associated with a 38% higher risk for CV death. Higher BMI was
ssociated with reduced mortality so that ESRD patients with a large waist circumference and
low BMI were at the highest risk. Visceral obesity underlies a high risk of all-cause and CV
ortality in ESRD patients.(continued on page A-22)
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tNTIPLATELET THERAPY1273Smokers May Receive More Benefit From Clopidogrelihar R. Desai, Jessica L. Mega, Songtao Jiang, Christopher P. Cannon, Marc S. Sabatine
lopidogrel is a pro-drug that requires oxidization by cytochrome P450 (CYP) enzymes to be
ransformed into its active metabolite. Cigarette smoking induces CYP1A2 and therefore
ight affect the pharmacokinetics and pharmacodynamics of clopidogrel. Desai and
olleagues investigated this interaction with a post-hoc analysis of the CLARITY–TIMI 28
Clopidogrel as Adjunctive Reperfusion Therapy–Thrombolysis In Myocardial Infarction 28)
rial, which randomized patients with ST-segment elevation myocardial infarction who
eceived aspirin, a fibrinolytic, and heparin to clopidogrel or placebo. Among those who
moked less than one-half pack/day, the addition of clopidogrel had no impact on the rate of
he composite clinical end point. In contrast, for those who smoked greater than one-half
ack/day, the addition of clopidogrel reduced the risk by nearly 50%. In this trial, the benefit
f clopidogrel was especially marked among those who smoked 10 cigarettes/day.EART FAILURE1279IVUS Virtual Histology Can Identify Cardiac Allograft VasculopathyEditorial Commentugenia Raichlin, Jang-Ho Bae, Sudhir S. Kushwaha, Ryan J. Lennon, Abhiram Prasad,
haranjit S. Rihal, Amir Lerman
ardiac allograft vasculopathy (CAV) is a unique form of accelerated atherosclerosis, which is
he leading cause of late morbidity and mortality in heart transplant patients. Raichlin and
olleagues used virtual histology intravascular ultrasound (VH-IVUS) to study 86 patients
ith CAV. Lesions were classified as inflammatory if the area of the necrotic core and dense
alcification accounted for 30% of the lesion. Subjects with an elevated rejection score were
ore likely to have inflammatory lesions. Those with inflammatory lesions were more likely
o have interval increases in plaque volume. This study demonstrates that VH-IVUS can
identify CAV and may be useful for further understanding of this disorder.(continued on page A-25)
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tMAGING IN HEART RHYTHM DISORDERS1289Newly Described Abnormality on MRI May Identify Early ARVD/CEditorial Comment
Maarten Groenink,arshan Dalal, Harikrishna Tandri, Daniel P. Judge, Nuria Amat, Robson Macedo, Rahul Jain,
rystal Tichnell, Amy Daly, Cynthia James, Stuart D. Russell, Theodore Abraham,
avid A. Bluemke, Hugh Calkins
lthough arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) is primarily
right-sided cardiomyopathy, the mutations that underlie the disorder may also affect the left
entricle (LV). The hypothesis of this study by Dalal and colleagues was that family members
arrying mutations in putative genes would be equally likely to develop right- or left-sided
bnormalities. In 25 individuals with mutations that may be linked to ARVD/C, only 4 had
inor abnormalities in the LV. On detailed cardiac magnetic resonance imaging, a focal
crinkling” of the right ventricular (RV) outflow tract and subtricuspid regions (“accordion
ign”) was observed in 60% of the mutation carriers and none of the noncarriers. The
accordion sign” is a promising tool for early diagnosis of ARVD/C that should be
nvestigated in larger cohorts.PRE-CLINICAL RESEARCH RE-CLINICAL RESEARCH1302Infusing BNP Directly to the Kidneys May Improve Efficacyorng H. Chen, Alessandro Cataliotti, John A. Schirger, Fernando L. Martin, Lynn K. Harstad,
ohn C. Burnett, Jr
he goal of this study by Chen and colleagues was to test the hypothesis that local renal
elivery of B-type natriuretic peptide (BNP) with direct infusions into the renal arteries
ould avoid systemic hypotension and improve natriuresis. In a dog model of pacing-induced
eart failure, systemic delivery of BNP was compared with direct renal artery infusions. Direct
enal delivery of BNP resulted in significant increases in diuresis, natriuresis, and glomerular
ltration rate compared with systemic infusions. Direct renal BNP did not decrease mean
rterial pressure, although systemic BNP did. Local renal BNP delivery is a novel strategy,
hich may overcome renal assistance to BNP by increasing delivery of BNP to the renal
ubules.(continued on page A-31)
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Editorial Commentlise Belaidi, Marie Joyeux-Faure, Christophe Ribuot, Sandrine H. Launois, Patrick Levy,
iane Godin-Ribuot
elaidi and colleagues investigated the involvement of the endothelin (ET) system in the
ardiovascular consequences of intermittent hypoxia (IH) as a model for what happens in
umans with obstructive sleep apnea. Chronic IH was applied to spontaneously hypertensive
SH) rats and normotensive controls. Chronic IH enhanced the development of hypertension;
his was accompanied by an increase in myocardial ET receptor expression and enhanced
eactivity to ET-1 in SH rats. Administration of bosentan, a mixed endothelin receptor
ntagonist, during chronic IH prevented the increase in blood pressure. In SH rats, activation
f the ET system by IH exacerbates the development of hypertension.YEAR IN CARDIOLOGY SERIES EAR IN CARDIOLOGY SERIES1326The Year in Atherothrombosisavier Sanz, Pedro R. Moreno, Valentin Fuster
anz, Moreno, and Fuster reviewed the most important articles related to atherothrombosis
ublished in 2008. The areas addressed include the epidemiology and public health impact
nd the underlying mechanisms of disease. There is a large section on early detection and risk
tratification including conventional and novel risk factors. The final section reviews the
iterature regarding the prevention and treatment of atherothrombosis.
